Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib (“Iressa”)‐sensitive and resistant xenograft modelsFumiko Taguchi, Kazuto Nishio|Cancer Science|2004Cited by 60